Spontaneous remission in canine myasthenia gravis: implications for assessing human MG therapies.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11739846.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The natural course of autoimmune canine MG was determined in 53 dogs with muscular weakness and a positive acetylcholine receptor antibody titer. Dogs were treated with anticholinesterase therapy, without immunosuppression. Spontaneous clinical and immunologic remission occurred in 47 of 53 dogs within an average of 6.4 months. Neoplasia was identified in the six dogs that did not spontaneously remit. This study questions the value of using canine MG in studies designed to assess the effect of immunotherapies.
Medical subject headings
- Autoimmune Diseases
- Dog Diseases
- Immunosuppressive Agents
- Myasthenia Gravis